The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Open accessAbstract
Recently, many types of in vitro 3-D culture systems have been developed to recapitulate the in vivo growth conditions of cancer. The cancer 3-D culture methods aim to preserve the biological characteristics of original tumors better than conventional 2-D monolayer cultures, and include tumor-derived organoids, tumor-derived spheroids, organotypic multicellular spheroids, and multicellular tumor spheroids. The 3-D culture methods differ in terms of cancer cell sources, protocols for cell handling, and the required time intervals. Tumor-derived spheroids are unique because they are purposed for the enrichment of cancer stem cells (CSCs) or cells with stem cell-related characteristics. These spheroids are grown as floating spheres and have been used as surrogate systems to evaluate the CSC-related characteristics of solid tumors in vitro. Because eradication of CSCs is likely to be of clinical importance due to their association with the malignant nature of cancer cells, such as tumorigenicity or chemoresistance, the investigation of tumor-derived spheroids may provide invaluable clues to fight against cancer. Spheroid cultures have been established from cancers including glioma, breast, colon, ovary, and prostate cancers, and their biological and biochemical characteristics have been investigated by many research groups. In addition to the investigation of CSCs, tumor-derived spheroids may prove to be instrumental for a high-throughput screening platform or for the cultivation of CSC-related tumor cells found in the circulation or body fluids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“3D patient-derived tumor models of CRC (i.e., organoid and spheroid cultures) allow maintenance and expansion of functionally relevant cell subfractions and harbor the patients' individual genetic lesions (Ishiguro et al., 2017;van de Wetering et al., 2015).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
In the citing paper
“Moreover, TICs that have the capacity to self-renew and maintain long-term tumor growth are usually rare within the tumor mass but highly enriched within spheroid cultures (Dieter et al., 2011;Ishiguro et al., 2017).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Identification and expansion of human colon-cancer-initiating cells
Ricci‐Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & Maria, R. D. (2006) · Nature · doi:10.1038/nature05384 · Cited by 4,001
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
Cited by
Sorted by citations
Items 201–300 of 530
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Hu, J., Liu, K., Ghosh, C., Khaket, T. P., Shih, H. A., & Kebebew, E. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03009-8 · Cited by 16
Durbin, K. R., Nottoli, M. S., & Jenkins, G. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-57789-y · Cited by 16
Life style factors, tumor cell plasticity and cancer stem cells
Chiodi, I., & Mondello, C. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108308 · Cited by 17
Lei, K. F., Ho, Y.-C., Huang, C., Huang, C., & Pai, P. C. (2021) · Talanta · doi:10.1016/j.talanta.2021.122259 · Cited by 16
Nieto, C., Vega, M. A., & del Valle, E. M. M. (2021) · Cancers · doi:10.3390/cancers13112526 · Cited by 16
Ashley, N., Ouaret, D., & Bodmer, W. F. (2018) · The Journal of Pathology · doi:10.1002/path.5179 · Cited by 16
Pinto, C. I. G., Bucar, S., Alves, V., Fonseca, A. I., Abrunhosa, A., da Silva, C. L., Guerreiro, J. F., & Mendes, F. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.609172 · Cited by 16
Hurd, M., Pino, J. J., Jang, K., Allevato, M. M., Vorontchikhina, M., Ichikawa, W., Zhao, Y., Gates, R., Villalpando, E., Hamilton, M., et al. (2023) · Genes & Development · doi:10.1101/gad.350736.123 · Cited by 16
Vitacolonna, M., Bruch, R., Schneider, R., Jabs, J., Hafner, M., Reischl, M., & Rudolf, R. (2024) · BMC Cancer · doi:10.1186/s12885-024-13329-9 · Cited by 15
Evans, L., Milward, K. F., Attanoos, R. L., Clayton, A., Errington, R. J., & Tabi, Z. (2021) · Biomedicines · doi:10.3390/biomedicines9030302 · Cited by 15
Application of Cancer Cell Reprogramming Technology to Human Cancer Research
Pan, X.-Y., Tsai, M.-H., Wuputra, K., Ku, C., Lin, W., Lin, Y., Kishikawa, S., Noguchi, M., Saito, S., Lin, C., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11703 · Cited by 14
Current experimental human tissue‐derived models for prostate cancer research
Kato, M., Sasaki, T., & Inoue, T. (2020) · International Journal of Urology · doi:10.1111/iju.14441 · Cited by 15
Shrestha, S., Garrett, S. H., Sens, D. A., Zhou, X., Guyer, R., & Somji, S. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.05.007 · Cited by 15
Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer
Lin, C., Zhang, Z., Yang, F. L., Gu, S., Zuo, J., Wu, Y. M., Zhang, J., Zhou, T., Zhang, Y., Chen, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06824-5 · Cited by 14
Li, J., Ek, F., Olsson, R., Belting, M., & Bengzon, J. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01422-8 · Cited by 14
Amer, J., Salhab, A., Jaradat, N. A., Abdallah, S., Abu-Rass, H., Hattab, S., Ghanim, M. A., & Alqub, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113885 · Cited by 17
Camacho-Gómez, D., Sorzabal-Bellido, I., Ortíz-de-Solórzano, C., García-Aznar, J., & Gómez-Benito, M. (2023) · iScience · doi:10.1016/j.isci.2023.107164 · Cited by 14
Harnessing graphene oxide nanocarriers for siRNA delivery in a 3D spheroid model of lung cancer
Grilli, F., Hassan, E. M., Variola, F., & Zou, S. (2023) · Biomaterials Science · doi:10.1039/d3bm00732d · Cited by 14
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Lamichhane, A., & Tavana, H. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00798-y · Cited by 16
Cui, Y., Ran, R., Da, Y., Zhang, H., Jiang, M., Qi, X., Zhang, W., Niu, L., Zhou, C., Zhou, C., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18374 · Cited by 14
Organoids in cancer therapies: a comprehensive review
Xin-Yi, J., Yan-Ran, W., Pin-Ru, D., Shi-Yi, Q., & Jiang, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1607488 · Cited by 17
Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
Akoury, E., Ahangar, P., Nour, A., Lapointe, J., Guérard, K., Haglund, L., Rosenzweig, D. H., & Weber, M. H. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0745-x · Cited by 14
Does resource availability help determine the evolutionary route to multicellularity?
Hamant, O., Bhat, R., Nanjundiah, V., & Newman, S. A. (2019) · Evolution & Development · doi:10.1111/ede.12287 · Cited by 14
Husain, K. M., Coppola, D., Yang, C. S., & Malafa, M. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-80911-z · Cited by 14
RetractedIntegration of Hydrogel Microparticles With Three-Dimensional Liver Progenitor Cell Spheroids
Gentile, S. D., Kourouklis, A. P., Ryoo, H., & Underhill, G. H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00792 · Cited by 14
Genetically modified cell spheroids for tissue engineering and regenerative medicine
Jiang, Z., Xu, Y., Fu, M., Zhu, D., Li, N., & Yang, G. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.033 · Cited by 12
Martínez-Ruiz, L., Florido, J., Rodríguez-Santana, C., López‐Rodríguez, A., Guerra‐Librero, A., Fernández-Gil, B. I., García-Tárraga, P., García‐Verdugo, J. M., Oppel, F., Sudhoff, H. H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115518 · Cited by 13
Gorji‐Bahri, G., Krishna, B. M., Hagerling, C., Orimo, A., Jirström, K., Παπαδάκος, Κ. Σ., & Blom, A. M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05083-0 · Cited by 13
Grimm, D. G., Corydon, T. J., Sahana, J., González-Torres, L. F., Kraus, A., Marchal, S., Wise, P. M., Simonsen, U., & Krüger, M. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf008 · Cited by 15
Perfusion Bioreactor Technology for Organoid and Tissue Culture: A Mini Review
Avena, P., Zavaglia, L., Casaburi, I., & Pezzi, V. (2025) · Onco · doi:10.3390/onco5020017 · Cited by 13
A high-throughput screen identifies inhibitors of lung cancer stem cells
She, X., Gao, Y., Zhao, Y. F., Yin, Y., & Dong, Z. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111748 · Cited by 15
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1
Salatino, A., Mirabelli, M., CHIEFARI, E. D., Greco, M., Vito, A. D., Bonapace, G., Brunetti, F. S., Crocerossa, F., Epstein, A. L., FOTI, D. P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051988 · Cited by 13
Okuyama, N. C. M., Ribeiro, D. L., da Rocha, C. Q., Pereira, É. R., Cólus, I. M. D. S., & Serpeloni, J. M. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116376 · Cited by 13
Primary colonospheres maintain stem cell‐like key features after cryopreservation
Eini, L., Naseri, M., Karimi‐Busheri, F., Bozorgmehr, M., Ghods, R., & Madjd, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29150 · Cited by 13
Combination of Auranofin and ICG-001 Suppress the Proliferation and Metastasis of Colon Cancer
Lin, Z., Li, Q., Zhao, Y., Lin, Z., Cheng, N., Zhang, D., Liu, G., Lin, J., Zhang, H., & Lin, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738085 · Cited by 13
Garakani, M. M., Cooke, M. E., Wertheimer, M. R., Rosenzweig, D. H., & Ajji, A. (2022) · Plasma Processes and Polymers · doi:10.1002/ppap.202100206 · Cited by 13
Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids
Ponomarev, A. S., Gilazieva, Z., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070106 · Cited by 11
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis
Signorile, M. L., Nicola, E. D., Forte, G., Sanese, P., Fasano, C., Disciglio, V., Marco, K. D., Latrofa, M., Cecco, L. D., Ficorilli, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02290-z · Cited by 15
Stackhouse, C. T., Gillespie, G. Y., & Willey, C. D. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_157 · Cited by 12
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
Marayati, R., Stafman, L. L., Williams, A. P., Bownes, L. V., Quinn, C. H., Aye, J. M., Stewart, J. E., Yoon, K. J., Anderson, J. C., Willey, C. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85289-0 · Cited by 12
Galán‐Martínez, J., Stamatakis, K., Sánchez‐Gómez, I., Vázquez‐Cuesta, S., Gironès, N., & Fresno, M. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13085 · Cited by 12
Morla, S., Ravikumar, O., O’Hara, C. P., Boothello, R. S., Vera, A., Abdelfadiel, E. I., Fayyad, R. M., Afosah, D. K., Sharon, C., Fernandez, L., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01511 · Cited by 12
Shao, S., Scholtz, L. U., Gendreizig, S., Martínez-Ruiz, L., Florido, J., Escames, G., Schürmann, M., Hain, C., Hose, L., Mentz, A., et al. (2023) · BMC Cancer · doi:10.1186/s12885-022-10481-y · Cited by 12
Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
Akoury, E., Luna, A. S. R. G., Ahangar, P., Gao, X., Zolotarov, P., Weber, M. H., & Rosenzweig, D. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081212 · Cited by 12
Samonig, L., Loipetzberger, A., Blöchl, C., Rurik, M., Kohlbacher, O., Aberger, F., & Huber, C. G. (2020) · Cells · doi:10.3390/cells9061397 · Cited by 12
Esch, J. S. A., Windmöller, B. A., Hanewinkel, J., Storm, J., Förster, C., Wilkens, L., Krüger, M., Kaltschmidt, B., & Kaltschmidt, C. (2020) · Cancers · doi:10.3390/cancers12092582 · Cited by 12
Model Systems for the Study of Malignant Melanoma
Gregg, R. K. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1205-7_1 · Cited by 13
Chia, J. Y., Miki, T., Mihara, H., & Tsutsumi, H. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116345 · Cited by 12
Marloye, M., Inam, H., Moore, C. J., Mertens, R. T., Ingels, A., Koch, M., Nowicki, M. O., Mathieu, V., Pritchard, J. R., Awuah, S. G., et al. (2022) · Inorganic Chemistry Frontiers · doi:10.1039/d2qi00423b · Cited by 11
Kulesza, J., Paluszkiewicz, E., & Augustin, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115780 · Cited by 11
Generating human skeletal myoblast spheroids for vascular myogenic tissue engineering
Minne, M., Terrie, L., Wüst, R., Hasevoets, S., Kerchove, K. V., Nimako, K., Lambrichts, I., Thorrez, L., & Declercq, H. (2024) · Biofabrication · doi:10.1088/1758-5090/ad2fd5 · Cited by 11
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
Pinto, C. I. G., Branco, A., Bucar, S., Fonseca, A. I., Abrunhosa, A., da Silva, C. L., Guerreiro, J. F., & Mendes, F. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01084-8 · Cited by 12
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
Loda, A., Semeraro, F., Parolini, S., Ronca, R., & Rezzola, S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189104 · Cited by 11
Shin, Y. S., Choi, J., Yoon, M., Yoo, M. K., Shin, D. H., & Lee, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s468935 · Cited by 11
Lanskikh, D., Kuziakova, O., Baklanov, I., Penkova, A. O., Doroshenko, V., Buriak, I., Zhmenia, V., & Kumeiko, V. V. (2024) · Cells · doi:10.3390/cells13242085 · Cited by 12
Cicero, A. L., Campora, S., Buglio, G. L., Cinà, P., Pinto, M. L., Scilabra, S. D., & Ghersi, G. (2025) · FEBS Journal · doi:10.1111/febs.70069 · Cited by 11
Osteomatrix as a personalized 3D tissue-specific invasion test-bed for oral carcinoma
Sudhakaran, S. V., Giri, P. S., Nellore, V., & Rath, S. N. (2023) · Biomaterials Science · doi:10.1039/d2bm01870e · Cited by 11
Cancer Stem Cells, Apoptosis Pathways and Mechanisms of Death Resistance
Safa, A. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00007-7 · Cited by 11
Role of RUNX2 in breast cancer development and drug resistance (Review)
Si, W., Chen, K., Zhang, L., & Li, F. (2023) · Oncology Letters · doi:10.3892/ol.2023.13762 · Cited by 11
Tang, B., Guo, M., Zhai, Y., Zhang, K., Ni, K., Zhang, Y., & Huang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05549-1 · Cited by 10
Jo, M. J., Yoon, M. S., Kim, S. Y., Lee, J. M., Kang, S. J., Park, C., Kim, J. S., Yoon, J., & Shin, D. H. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00705-7 · Cited by 10
Cunningham, R., Jia, S., Purohit, K. P., Nosková, M., Maniak, M. K., Lin, Y., Hui, N. S., Graham, R. E., Rossi, A. G., Cholewa-Waclaw, J., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202503241 · Cited by 12
Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids
Park, H., Hwang, S., Jeong, J.-Y., Jung, S. G., Choi, M. C., Joo, W. D., Song, S. H., Lee, C. M., & An, H. J. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00618-7 · Cited by 10
Concise review: Cancer cell reprogramming and therapeutic implications
Xiao, X., Chen, H., Yang, L., Xie, G., Shimuzu, R., & Murai, A. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101503 · Cited by 10
Organoids in the Clinic: A Systematic Review of Outcomes
Hofmann, B., Zinöcker, S., Holm, S., Lewis, J., & Kavouras, P. (2022) · Cells Tissues Organs · doi:10.1159/000527237 · Cited by 11
Huang, S., Lu, F., An, G., Zhang, X., Zhao, Z., Han, R. F., Lei, F., Zhang, Y., Luo, A., Jing, X., et al. (2018) · Cancer Science · doi:10.1111/cas.13574 · Cited by 10
Salehizadeh, S., Hasanzad, M., Kadijani, A. A., & Akbari, A. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00295-w · Cited by 10
Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells
Uwada, J., Mukai, S., Terada, N., Nakazawa, H., Islam, M. S., Nagai, T., Fujii, M., Yamasaki, K., Taniguchi, T., Kamoto, T., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119554 · Cited by 10
Bisconti, F., Abreu, H., Nguyen, T. D., Stolfi, F., Corbezzolo, N., Gigli, G., Raineri, D., Cappellano, G., Polini, A., Gervaso, F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1712796 · Cited by 9
Ishtiah, A. A., & Yahaya, B. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_32 · Cited by 9
To, H. T. N., Le, Q. A., Bui, H. T. T., Park, J., & Kang, D. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb45010018 · Cited by 9
Matsubara, H., Miyoshi, H., Kakizaki, F., Morimoto, T., Kawada, K., Yamamoto, T., Obama, K., Sakai, Y., & Taketo, M. M. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0411 · Cited by 9
The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer
Sunaga, N., Kaira, K., Shimizu, K., Tanaka, I., Miura, Y., Nakazawa, S., Ohtaki, Y., Kawabata‐Iwakawa, R., Sato, M., Girard, L., et al. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15169 · Cited by 9
Strategies for the Isolation and Identification of Gastric Cancer Stem Cells
Wang, J., Qu, J., Hou, Q., Huo, X., Zhao, X., Chang, L., & Xu, C. (2024) · Stem Cells International · doi:10.1155/2024/5553852 · Cited by 9
Kim, J. H., Frantz, A. M., Sarver, A. L., Gorden, B. H., Lewellen, M., O’Brien, T. D., Dickerson, E. B., & Modiano, J. F. (2017) · Veterinary and Comparative Oncology · doi:10.1111/vco.12368 · Cited by 9
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Laranjo, M., Carvalho, M. J., Serambeque, B., Alves, A., Marto, C. M., Silva, I., Paiva, A. A., & Botelho, M. F. (2020) · Journal of Visualized Experiments · doi:10.3791/60022 · Cited by 9
Li, A., & Yang, P. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101365 · Cited by 10
Heise, T., & Sommer, G. (2021) · Cancers · doi:10.3390/cancers13020343 · Cited by 9
Ohnishi, K., Tani, T., Tojo, N., & Sagara, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.009 · Cited by 9
Persistent effects of pair bonding in lung cancer cell growth in monogamous Peromyscus californicus
Naderi, A., Soltanmaohammadi, E., Kaza, V., Barlow, S., Chatzistamou, I., & Kiaris, H. (2021) · eLife · doi:10.7554/elife.64711 · Cited by 8
Ismail, F., Zakaria, Y., Isa, M., Hassan, N. F. N., & Tan, S. C. (2024) · Sains Malaysiana · doi:10.17576/jsm-2024-5303-14 · Cited by 8
Xuan, Y., Xu, J., Que, H., & Zhu, J. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110216 · Cited by 8
Zimina, T. M., Sitkov, N. O., Газинурович, Г. К., Mikhailova, N., Combs, S. E., & Shevtsov, M. A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1452298 · Cited by 14
Microbial metabolites in tumor metabolic reprogramming and immunotherapy: new insights
Wang, Y., Huang, D., Wang, R., Yin, J.-J., Pei, J., & Zhang, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1706040 · Cited by 9
Salivary gland cell aggregates are derived from self-organization of acinar lineage cells
Varghese, J. J., Hansen, M. E., Sharipol, A., Ingalls, M. H., Ormanoski, M. A., Newlands, S. D., Ovitt, C. E., & Benoit, D. S. W. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.10.017 · Cited by 8
Madajewski, B., Boatman, M. A., Martínez, I., Carter, J. H., & Bey, E. A. (2023) · Genes · doi:10.3390/genes14030607 · Cited by 8
Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
Pinho, S., Anjo, S. I., & Cunha‐Oliveira, T. (2023) · Antioxidants · doi:10.3390/antiox12051072 · Cited by 10
Downregulation of circ-Foxo3 in breast cancer stem-like cells
Kamalabadi‐Farahani, M., Atashi, A., & Eslami, M. M. (2023) · BMC Research Notes · doi:10.1186/s13104-023-06405-z · Cited by 8
Rocking- and diffusion-based culture of tumor spheroids-on-a-chip
Tian, D., Mao, Z., Wang, L., Huang, X., Wang, W., Luo, H., Peng, J., & Chen, Y. (2024) · Lab on a Chip · doi:10.1039/d3lc01116j · Cited by 8
Nguyen, P. H., Hương, L. T., Can, D. Q. H., Le, T. N. T., Hoang, V., Ngo, H. P., Do, T. T. H., Nguyen, T. K. O., & Hoang, V. H. (2025) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2025.103521 · Cited by 8
Fabricating Silicon Resonators for Analysing Biological Samples
Kumemura, M., Pekin, D., Menon, V. A., SEUNINGEN, I. V., Collard, D., & Tarhan, M. C. (2021) · Micromachines · doi:10.3390/mi12121546 · Cited by 8
Transmigration of Trypanosoma cruzi Trypomastigotes through 3D Spheroids Mimicking Host Tissues
Rodríguez, M. E., Rizzi, M., Caeiro, L. D., Masip, Y. E., Sánchez, D. O., & Tekiel, V. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9148-8_12 · Cited by 7
Moreira, M. P., Brayner, F. A., Alves, L. C., Cassali, G. D., & Silva, L. M. (2019) · European Biophysics Journal · doi:10.1007/s00249-019-01393-0 · Cited by 8
Fukui, F., Hayashi, S., & Yamaguchi, Y. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105698 · Cited by 8
Targeting Dormant Ovarian Cancer Cells In Vitro and in an In Vivo Mouse Model of Platinum Resistance
Huang, Z., Kondoh, E., Visco, Z. R., Baba, T., Matsumura, N., Dolan, E. L., Whitaker, R. S., Konishi, I., Fujii, S., Berchuck, A., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0119 · Cited by 9
Full‐Length TrkB Variant in NSCLC Is Associated with Brain Metastasis
Lombardi, M., D’Ascanio, M., Scarpino, S., Scozzi, D., Giordano, M., Costarelli, L., Raj, E. R., Mancini, R., Cardillo, G., Cardaci, V., et al. (2020) · BioMed Research International · doi:10.1155/2020/4193541 · Cited by 7
Connexin46 in the nucleus of cancer cells: a possible role as transcription modulator
Fernández-Olivares, A., Orellana, V. P., Llanquinao, J., Núñez, G., Pérez, P. E., Contreras-Riquelme, S., Martín, A. J. M., Mammano, F., Alfaro, I. E., Calderón, J. F., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02151-w · Cited by 7
Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies
D’Antonio, C., & Liguori, G. L. (2025) · Biology · doi:10.3390/biology14111490 · Cited by 8
The treatment effects of Trametes Robiniophila Murr against colorectal cancer: A mini-review
Li, B., Cao, Q., & Liu, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.981516 · Cited by 7
Skurikhin, Е. G., Ermakova, N. N., Zhukova, М. А., Pershina, О. V., Pan, E. S., Pakhomova, A. V., Kogai, L., Goldberg, V., Simolina, E., Skurikhina, V. E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810853 · Cited by 7
Metadata
- Authors
- Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K.
- Affiliations
- Niigata University (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Okamoto, Koji
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2017-03
- Volume
- 108
- Issue
- 3
- Pages
- 283-289
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- PMC
- PMC5378268
- OpenAlex
- W2570959155
- Cited by
- 530
- References
- 80
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 67 · 2023: 69 · 2022: 64 · 2021: 65 · 2020: 70 · 2019: 55 · 2018: 33 · 2017: 11
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancer Science (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- National Cancer Center
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- cancer stem cells, tumor spheroids, tumor organoids, chemoresistance, tumorigenicity, high-throughput screening, circulating tumor cells, glioma, breast cancer, colon cancer, ovarian cancer, prostate cancer
- MeSH terms
- Humans, Neoplasms, Tumor Cells, Cultured, Neoplastic Stem Cells, Spheroids, Cellular, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review